SCHEMBL24022836

SCHEMBL24022836

CC(=O)Nc1ccc(/C(N)=N/N=C\N)cc1F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 8/20 0.62
▸ HDAC6 Q9UBN7 3/20 0.62
▸ CA1 P00915 2/20 0.47
▸ CA2 P00918 2/20 0.47
▸ CA9 Q16790 2/20 0.47
▸ NEU3 Q9UQ49 1/20 0.45
▸ HDAC3 O15379 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ NCOR2 Q9Y618 1/20 0.42
▸ KLK1 P06870 1/20 0.40
▸ KLK5 Q9Y337 1/20 0.40
▸ F10 P00742 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ GAA P10253 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KIF11 P52732 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24022841 0.85 NEU3 (0.46) HDAC1HDAC6NEU3KLK1KLK5
SCHEMBL24022755 0.77 NEU3 (0.46) HDAC1HDAC6NEU3HDAC2GAA
SCHEMBL22043785 0.76 KDM4E (0.42) HDAC1HDAC6NEU3CYP1A2CYP2C19
SCHEMBL22043759 0.76 DGAT1 (0.46) HDAC1HDAC6NEU3KLK1KLK5
SCHEMBL24022848 0.76 HDAC1 (0.50) HDAC1HDAC6SMN1; SMN2NPC1RAB9A
SCHEMBL7902823 0.76 HDAC1 (0.65) HDAC1HDAC6CA1CA2CA9
SCHEMBL22043753 0.75 EPHX2 (0.39) HDAC1HDAC6NEU3RAB9AALDH1A1
SCHEMBL6106476 0.75 HDAC1 (0.73) HDAC1HDAC6CA1CA2CA9
SCHEMBL29808947 0.75 HDAC1 (0.73) HDAC1HDAC6CA1CA2CA9
SCHEMBL8367216 0.74 HDAC1 (0.71) HDAC1HDAC6CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3909944-A1 NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY Rigshospitalet (DK) 2021-11-17 — — EP disclosed
Send feedback